Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,436,959 papers from all fields of science
Search
Sign In
Create Free Account
tegafur-uracil
Known as:
UFT
, Uracil and Tetrahydrofuranyl-5-Fluorouracil
, UFUR
Expand
A formulated therapeutic oral agent consisting of a combination of the 5-fluorouracil (5-FU) congener prodrug tegafur (tetrahydrofuranyl-5…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
NCIt Antineoplastic Agent Terminology
Tegafur
Uracil
fluorouracil-uracil/leucovorin calcium
Expand
Narrower (1)
Uftoral
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Antiangiogenic effect of capecitabine combined with ginsenoside Rg3 on breast cancer in mice.
Qingyuan Zhang
,
Xinmei Kang
,
Bao-feng Yang
,
Jing-xuan Wang
,
Fang Yang
Cancer Biotherapy and Radiopharmaceuticals
2008
Corpus ID: 22528236
Capecitabine is a novel fluoropyrimidine carbamate, which has a broader spectrum of antitumor activity than other…
Expand
2004
2004
Survival benefit of oral UFT for adjuvant chemotherapy after completely resected non-small-cell lung cancer.
C. Hamada
,
M. Ohta
,
+5 authors
N. Matsuoka
Journal of Clinical Oncology
2004
Corpus ID: 22851159
7002 Background: Survival rate should be used as the primary endpoint in clinical trials assessing the response of non-small-cell…
Expand
2003
2003
Powering DNA repair through substrate electrostatic interactions.
Y. L. Jiang
,
Y. Ichikawa
,
F. Song
,
J. Stivers
Biochemistry
2003
Corpus ID: 7799466
The reaction catalyzed by the DNA repair enzyme uracil DNA glycosylase (UDG) proceeds through an unprecedented stepwise mechanism…
Expand
Highly Cited
2002
Highly Cited
2002
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy.
Jaime Feliu
,
J. Calvillo
,
+7 authors
M. Barón
Annals of Oncology
2002
Corpus ID: 24855638
BACKGROUND The object of this phase II study was to assess the impact of preoperative external radiation therapy combined with…
Expand
Highly Cited
2001
Highly Cited
2001
Improved survival with oral administration of enteric‐coated tegafur/uracil for advanced stage IV‐A hepatocellular carcinoma
T. Ishikawa
,
T. Ichida
,
+8 authors
H. Asakura
Journal of Gastroenterology and Hepatology
2001
Corpus ID: 573651
Background and Aims: There is currently no proven chemotherapy regimen for hepatocellular carcinoma (HCC). The principal…
Expand
Highly Cited
1996
Highly Cited
1996
Postoperative adjuvant chemotherapy after radical hepatic resection for hepatocellular carcinoma (HCC).
H. Kohno
,
N. Nagasue
,
+6 authors
T. Nakamura
Hepato-Gastroenterology
1996
Corpus ID: 22078269
BACKGROUND/AIMS This prospective randomized study was aimed to clarify the efficacy of epirubicin after radical hepatic resection…
Expand
1990
1990
Postgastrectomy prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma.
Y. Maehara
,
A. Watanabe
,
Y. Kakeji
,
H. Baba
,
S. Kohnoe
,
K. Sugimachi
American Journal of Surgery
1990
Corpus ID: 35229790
1987
1987
[Report on nationwide pooled data and cohort investigation in UFT phase II study].
K. Ota
,
T. Taguchi
,
K. Kimura
Gan to kagaku ryoho. Cancer & chemotherapy
1987
Corpus ID: 32130862
Based on the overall results of a UFT phase II study made in 104 institutions in Japan from April of 1979 to September of 1980…
Expand
Highly Cited
1982
Highly Cited
1982
Fatty tumours of the uterus.
D. Pounder
Journal of Clinical Pathology
1982
Corpus ID: 2456161
Uterine fatty tumours (UFT) are uncommon and have received little attention in the English literature. They have aroused interest…
Expand
Highly Cited
1970
Highly Cited
1970
Enzymic determination of uracil nucleotides in tissues.
D. Keppler
,
J. Rudigier
,
K. Decker
Analytical Biochemistry
1970
Corpus ID: 33127913
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE